One for All-Can We Have and Do We Want a First-Line Monotherapy for Epilepsy?
作者信息
Steriade Claude
机构信息
NYU Langone Comprehensive Epilepsy Center.
出版信息
Epilepsy Curr. 2024 Feb 6;24(2):108-110. doi: 10.1177/15357597241227655. eCollection 2024 Mar-Apr.
Abstract
摘要
相似文献
1
One for All-Can We Have and Do We Want a First-Line Monotherapy for Epilepsy?一种适用于所有人——我们能否拥有以及是否想要一种癫痫一线单药治疗方案？
Epilepsy Curr. 2024 Feb 6;24(2):108-110. doi: 10.1177/15357597241227655. eCollection 2024 Mar-Apr.
2
Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.癫痫的抗癫痫药物单药治疗：个体参与者数据的网状荟萃分析
Cochrane Database Syst Rev. 2017 Dec 15;12(12):CD011412. doi: 10.1002/14651858.CD011412.pub3.
3
Vigabatrin versus carbamazepine monotherapy for epilepsy.氨己烯酸与卡马西平单药治疗癫痫的比较
Cochrane Database Syst Rev. 2015 Nov 18;2015(11):CD008781. doi: 10.1002/14651858.CD008781.pub3.
4
Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.癫痫的抗癫痫药物单药治疗：个体参与者数据的网状Meta分析
Cochrane Database Syst Rev. 2017 Jun 29;6(6):CD011412. doi: 10.1002/14651858.CD011412.pub2.
5
Vigabatrin versus carbamazepine monotherapy for epilepsy.氨己烯酸与卡马西平单药治疗癫痫的对比
Cochrane Database Syst Rev. 2012 Jan 18;1:CD008781. doi: 10.1002/14651858.CD008781.pub2.
6
Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.抗癫痫药物单药治疗癫痫：一项个体参与者数据的网络荟萃分析。
Cochrane Database Syst Rev. 2022 Apr 1;4(4):CD011412. doi: 10.1002/14651858.CD011412.pub4.
7
Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy.拉莫三嗪单药治疗儿童和青少年癫痫的疗效与安全性。
Eur J Paediatr Neurol. 2009 Mar;13(2):141-5. doi: 10.1016/j.ejpn.2008.03.002. Epub 2008 Jun 27.
8
The Efficacy and Tolerability of Levetiracetam as a First Line Monotherapy in Childhood Epilepsy.左乙拉西坦作为儿童癫痫一线单药治疗的疗效和耐受性。
Ir Med J. 2020 Feb 13;113(2):18.
9
Perampanel as monotherapy or first adjunctive therapy in pediatric and adult patients with epilepsy: the first United States-based phase IV open-label ELEVATE study.在儿科和成年癫痫患者中单药或作为一线附加治疗应用吡仑帕奈的美国首个基于 IV 期的开放标签 ELEVATE 研究。
J Neurol. 2024 Jul;271(7):4587-4598. doi: 10.1007/s00415-024-12399-w. Epub 2024 May 10.
10
Effectiveness of dose-escalated topiramate monotherapy and add-on therapy in neurosurgery-related epilepsy: A prospective study.剂量递增托吡酯单药治疗和添加治疗在神经外科相关癫痫中的疗效：一项前瞻性研究。
Medicine (Baltimore). 2020 Dec 24;99(52):e23771. doi: 10.1097/MD.0000000000023771.
本文引用的文献
1
Patterns of antiseizure medication utilization in the Human Epilepsy Project.人类癫痫项目中抗癫痫药物的使用模式。
Epilepsia. 2023 Dec;64(12):3196-3204. doi: 10.1111/epi.17802. Epub 2023 Oct 27.
2
Levetiracetam vs Lamotrigine as First-Line Antiseizure Medication in Female Patients With Idiopathic Generalized Epilepsy.左乙拉西坦与拉莫三嗪作为特发性全面性癫痫女性患者一线抗癫痫药物的比较。
JAMA Neurol. 2023 Nov 1;80(11):1174-1181. doi: 10.1001/jamaneurol.2023.3400.
3
The EpiPick algorithm to select appropriate antiseizure medications in patients with epilepsy: Validation studies and updates.
Epilepsia. 2022 Jan;63(1):254-255. doi: 10.1111/epi.17129. Epub 2021 Nov 19.
4
The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.SANAD II 研究：丙戊酸钠与左乙拉西坦治疗新诊断的全面性和不可分类癫痫的有效性和成本效益：一项开放标签、非劣效性、多中心、4 期、随机对照试验。
Lancet. 2021 Apr 10;397(10282):1375-1386. doi: 10.1016/S0140-6736(21)00246-4.
5
The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.SANAD II 研究：左乙拉西坦、唑尼沙胺或拉莫三嗪治疗新诊断局灶性癫痫的有效性和成本效益：一项开放标签、非劣效性、多中心、4 期、随机对照试验。
Lancet. 2021 Apr 10;397(10282):1363-1374. doi: 10.1016/S0140-6736(21)00247-6.
6
A pragmatic algorithm to select appropriate antiseizure medications in patients with epilepsy.一种实用的算法，用于在癫痫患者中选择合适的抗癫痫药物。
Epilepsia. 2020 Aug;61(8):1668-1677. doi: 10.1111/epi.16610. Epub 2020 Jul 22.
7
The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial.丙戊酸盐、拉莫三嗪或托吡酯治疗全身性和无法分类癫痫有效性的 SANAD 研究：一项非盲法随机对照试验。
Lancet. 2007 Mar 24;369(9566):1016-26. doi: 10.1016/S0140-6736(07)60461-9.
8
The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial.卡马西平、加巴喷丁、拉莫三嗪、奥卡西平或托吡酯治疗部分性癫痫有效性的SANAD研究：一项非盲随机对照试验。
Lancet. 2007 Mar 24;369(9566):1000-15. doi: 10.1016/S0140-6736(07)60460-7.
Zotero 插件